**Chapter 7**

*Gene Expression and Control*

10.1042/CS20130706

10.2337/db13-1412

10.1038/ki.2015.331

AngII-mediated hypertensive nephropathy in a mouse model of hypertension. Clinical Science (London, England). 2014;**127**:195-208. DOI:

[119] Dube N, Kooistra MR, Pannekoek WJ, Vliem MJ, Oorschot V, et al. The RapGEF PDZ-GEF2 is required for maturation of cell-cell junctions. Cellular Signalling. 2008;**20**:1608-1615. DOI: 10.1016/j.cellsig.2008.05.006

[120] Xiao L, Zhu X, Yang S, Liu F, Zhou Z, et al. Rap1 ameliorates renal tubular injury in diabetic nephropathy. Diabetes. 2014;**63**:1366-1380. DOI:

[121] Yiu WH, Wong DW, Wu HJ, Li RX, Yam I, Chan LY, Leung JC, Lan HY, Lai KN, Tang SC. Kallistatin protects against diabetic nephropathy in db/ db mice by suppressing AGE-RAGEinduced oxidative stress. Kidney International. 2016;**89**:386-398. DOI:

[122] Du B, Ma LM, Huang MB, Zhou H, Huang HL, et al. High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Letters. 2010;**584**:811-816. DOI:

10.1016/j.febslet.2009.12.053

[123] Roderburg C, Urban GW,

[124] Miller DL. Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Progress in Biophysics and Molecular Biology. 2007;**93**:314-330. DOI: 10.1016/j.pbiomolbio.2006.07.027

Bettermann K, Vucur M, Zimmermann H, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;**53**: 209-218. DOI: 10.1002/hep.23922

**120**
